ACBM
Acro Biomedical Co., Ltd.Company with tickers: ACBM
CIK
1622996
Shares Outstanding
60,042,000
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $0 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $60,271 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Research & Development | — | ||||
| Operating Income | $-60,271 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Net Income | $-43,774 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| EPS (Basic) | — | ||||
| EPS (Diluted) | $0.00 | USD/shares | 2026-03-31 | 10-Q | 2026-05-05 |